ClinConnect ClinConnect Logo
Search / Trial NCT06882681

Silymarin Bioavailability Study

Launched by ISURA · Mar 12, 2025

Trial Information

Current as of April 26, 2025

Completed

Keywords

Milk Thistle Silymarin Lipo Micel Pharmacokinetics Bioavailability Absorption Micelles

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female aged 21- 65 years
  • Healthy, good physical condition
  • Voluntary, written, informed consent to participate in the study.
  • Exclusion Criteria:
  • Serious acute or chronic diseases e.g. liver, kidney, or gastrointestinal diseases
  • Contraindication or allergies to milk thistle
  • Pregnancy or breastfeeding
  • Concurrent use of supplements and/or medications
  • Participation in another investigational study

About Isura

Isura is a pioneering clinical trial sponsor dedicated to advancing healthcare through rigorous research and innovative solutions. Specializing in the oversight and management of clinical studies, Isura is committed to ensuring the highest standards of quality, safety, and compliance throughout the trial process. With a focus on fostering collaboration among stakeholders, including researchers, healthcare providers, and regulatory bodies, Isura aims to expedite the development of effective therapies while enhancing patient outcomes. Their expertise in diverse therapeutic areas positions them as a trusted partner in navigating the complexities of clinical research.

Locations

Burnaby, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Julia Solnier, PhD

Principal Investigator

Isura

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported